ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,709.54
0.01%
Dow Jones
42,196.52
0.09%
US Dollar vs MXN
19.41449
-1.11%
Brent Oil
74.565
0.19%
Bitcoin
60,383.70
-0.74%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/10/202415:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HLXHelix Energy Solutions Group Inc
02/10/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUZENuZee Inc
02/10/202415:09Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
02/10/202415:09Business WireBNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces DistributionNYSE:DMBBNY Mellon Municipal Bond Infrastructure Fund Inc
02/10/202415:08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:KEYSKeysight Technologies Inc
02/10/202415:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACCDAccolade Inc
02/10/202415:08PR Newswire (Canada)PRIMARIS REIT ANNOUNCES $69.6 MILLION BOUGHT DEAL TREASURY AND SECONDARY OFFERING OF TRUST UNITS IN CONNECTION WITH RECENT ACQUISITIONTSX:PMZ.UNPrimaris Real Estate Investment Trust
02/10/202415:07Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:SGRPSpar Group Inc
02/10/202415:06Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PBMWWPsyence Biomedical Ltd
02/10/202415:06PR Newswire (Canada)Tajiri to Close First Tranche of Non-Brokered Private PlacementTSXV:TAJTajiri Resources Corp
02/10/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:LEVILevi Strauss and Co
02/10/202415:05GlobeNewswire Inc.PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per ShareNYSE:PFLTPennantPark Floating Rate Capital Ltd
02/10/202415:05GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5 Million OfferingTSX:BCTBriaCell Therapeutics Corp
02/10/202415:05GlobeNewswire Inc.QCR Holdings, Inc. to Report Third Quarter 2024 Financial ResultsNASDAQ:QCRHQCR Holdings Inc
02/10/202415:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SMTKSmartKem Inc
02/10/202415:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HTLMHomesToLife Ltd
02/10/202415:05GlobeNewswire Inc.Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyNASDAQ:CDXSCodexis Inc
02/10/202415:05GlobeNewswire Inc.PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per ShareNYSE:PNNTPennantPark Investment Corporation
02/10/202415:05Business WireTandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:TNDMTandem Diabetes Care Inc
02/10/202415:05Business WireAMERISAFE Announces 2024 Third Quarter Earnings Release and Conference Call ScheduleNASDAQ:AMSFAMERISAFE Inc
02/10/202415:05Business WireArcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell CarcinomaNYSE:RCUSArcus Biosciences Inc
02/10/202415:05Business WireBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCYCBicycle Therapeutics PLC
02/10/202415:05Business WireRyan Specialty Completes Acquisition of Certain Assets of Geo Underwriting EuropeNYSE:RYANRyan Specialty Holdings Inc
02/10/202415:05Business WireAXT, Inc. Schedules Third Quarter 2024 Earnings Release for Oct. 31, 2024NASDAQ:AXTIAXT Inc
02/10/202415:05Business WireAstera Labs Announces Conference Call to Review Third Quarter 2024 Financial ResultsNASDAQ:ALABAstera Labs Inc
02/10/202415:05Business WireThe St. Joe Company Announces the Opening of Starbucks at Watersound® Town CenterNYSE:JOESt Joe Company
02/10/202415:05Business WireRoyal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Wednesday, October 16, 2024NASDAQ:RGLDRoyal Gold Inc
02/10/202415:05Business WireUlta Beauty to Host 2024 Investor DayNASDAQ:ULTAUlta Beauty Inc
02/10/202415:05Business WireAppLovin to Announce Third Quarter 2024 ResultsNASDAQ:APPApplovin Corporation
02/10/202415:05GlobeNewswire Inc.Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1NASDAQ:KAKineta Inc

Su Consulta Reciente

CCOM
US500
US 500
COIN
XRPUSD
Ripple
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
COIN
AVAXUSD
Avalanche
COIN
SOLUSD
Solana
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados